NCT06241144 Supporting Lifestyle Changes After Delivery
| NCT ID | NCT06241144 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oulu University Hospital |
| Condition | Obesity, Maternal |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-02-09 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-02-09 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Use of information and communication technology -based health behavior change support system in modifying lifestyle after delivery among women with obesity.
Eligibility Criteria
Inclusion Criteria: * Pre-pregnancy BMI ≥ 30.0 kg/m\^2 * Smartphone user Exclusion Criteria: * Eating disorder * Severe mental disorder * Use of other lifestyle support system or medication * Non-Finnish speaker
Contact & Investigator
Marja Vääräsmäki, Professor
PRINCIPAL INVESTIGATOR
Research Unit of Clinical Medicine, University of Oulu, Oulu University Hospital
Frequently Asked Questions
Who can join the NCT06241144 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Obesity, Maternal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06241144 currently recruiting?
Yes, NCT06241144 is actively recruiting participants. Contact the research team at sanna.mustaniemi@oulu.fi for enrollment information.
Where is the NCT06241144 trial being conducted?
This trial is being conducted at Oulu, Finland.
Who is sponsoring the NCT06241144 clinical trial?
NCT06241144 is sponsored by Oulu University Hospital. The principal investigator is Marja Vääräsmäki, Professor at Research Unit of Clinical Medicine, University of Oulu, Oulu University Hospital. The trial plans to enroll 200 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.